Navigation Links
Mentice VIST(TM) New and Enhanced Carotid and Coronary Training Modules Take Medical Simulation Training to the Next Level
Date:12/1/2008

GOTHENBURG, Sweden, December 1 /PRNewswire/ -- Mentice proudly announces the launch of two new products for endovascular simulation training - the Mentice VIST 7.7 enhanced training modules for Carotid and Coronary interventions. New features such as vital signs, complications, medication management and measurement functionality add to the clinical realism and enhance the educational value of simulation training.

"Features like vital signs and complications imply a dynamic patient representation which requires further decision making, planning and patient interactions," said Goran Malmberg, President/CEO of Mentice.

"On top of the new functionalities, we are launching new anatomical content and further training alternatives such as CTO (Chronic Total Occlusion) lesions and cases that enable transradial access," Malmberg continues. "This launch truly shows that Mentice continues to be a driver of the medical simulation market and it further strengthens our position as a leader in the field of endovascular simulation training."

With the launch of the VIST 7.7 training modules Mentice adds to the already wide range of training opportunities for Carotid and Coronary interventions - all together a total of 42 patient cases. A summary of the new features are presented below.

Vital signs - All cases have vital signs recognition and response.

Complications - A select number of cases include complications that will occur as a result of user actions. One example, engaging a catheter too deeply into an ostium may result in vascular spasm.

Medication management - Medication administration is included to manage the complications the trainees encounter. One example of this would be the injection of Nitroglycerin for treatment of a spasm.

Measurement functionality - New measurement functionality has been added to allow the users to easily measure the diameters and length of lesions, reference vessels, etc - adding additional realism to the equipment selection process.

Mentice - improving patient safety

Mentice is a world leader in medical simulation, providing qualified solutions for training, education and assessment opportunities. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a safe environment within the fields of endovascular intervention and endoscopic surgery. The advantages of training with Mentice solutions are well documented enhancing clinical performance, reducing cost, and, in the long term, improving patient safety.

    For further information, please contact
    Goran Malmberg, President/CEO of Mentice.
    Office: +46-31-33-99-401,
    Web:http://www.mentice.com


'/>"/>
SOURCE Mentice AB
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas
2. Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
3. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
4. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
5. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
6. The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain
7. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
8. NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information
9. Brookdale Senior Living Announces Enhanced Web Site
10. T cell immunity enhanced by timing of interleukin-7 therapy
11. The HealthCentral Network and Sister to Sister Form Alliance to Develop Enhanced Online Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: